Background Genomic screening uncovered interferon-gamma (IFNγ) pathway defects in tumours refractory to immune checkpoint blockade (ICB). However, its non-mutational regulation and reversibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback